跳至主要内容
临床试验/ISRCTN13671612
ISRCTN13671612进行中(未招募)Unknown

Evaluating the efficacy of a six-session solution-focused brief therapy versus case management for youths with mental health distress: the CHAT Supportive Interventions (CSI) randomized controlled trial

Institute of Mental Health0 个研究点目标入组 124 人开始时间: 2023年9月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • All study participants must meet the criteria below:
  • 1. 16-30 years old
  • 2. English-speaking and English-literate
  • 3. Non-specific mental distress (Clinical Stage 1a), subsyndromal or subthreshold symptoms (Clinical Stage 1b), or are experiencing a first episode of a full defined syndrome (Clinical Stage 2) based on CHAT assessment
  • Additional criteria for participants in the intervention arm:
  • 1. Committed to attend all six intervention sessions, weekly (either through face-to-face or teleconferencing), to be completed in 8 weeks
  • 2. Willingness to be registered as a client with the Institute of Mental Health Singapore (so that therapy can be provided, as per IMH protocol)

排除标准

  • All subjects meeting any of the exclusion criteria at baseline will be excluded from participation. Subjects who:
  • 1. Have high suicidal risk (as determined by Columbia Suicide Safety Rating Scale, during CHAT assessment)
  • 2. Have active and florid psychosis symptoms
  • 3. Have significant cognitive impairments
  • 4. Are participating in other active psychotherapy or psychiatric medication treatment
  • 5. Are below 21 years old and do not have parental consent to participate in the study
  • 6. Decline to be registered as a client at IMH (if they have been randomised to the intervention arm)

研究者

相似试验

进行中(未招募)
1 期
A 6 week, multi centre study to evaluate the efficacy and safety of E45 complete emollient therapy and E45 itch relief cream in the treatment of mild to moderate atopic eczema compared to a patients normal emollient regime defined as the frequent use of emollient/s (not containing lauromacrogols) listed in the BNF. - Harbour StudyAtopic Eczema
EUCTR2006-000877-30-GBReckitt Benckiser Healthcare International180
已完成
不适用
Evaluation of the effectiveness of an educational program for people with addiction's safer public speakingAddictive disorders
JPRN-UMIN000038030Graduate School of Health Sciences, Kobe University90
已完成
2 期
Study of effectiveness of an essential oil mix (P798208 08) in healthy volunteers with oily skin.
CTRI/2011/07/001892LOREAL RESEARCH37
已完成
不适用
Clinical trial to evaluate the influence of 6 day-dexamethasone (inducer of CES1)Diseases of th respiratory system
KCT0001533Bundang CHA General Hospital20
进行中(未招募)
1 期
Efficacy study to evaluate fluticasone furoate /vilanterol Inhalation Powder delivered once daily via the Dry Powder Inhaler Ellipta™ compared with usual ICS/LABA maintenance therapy delivered by Dry Powder Inhaler in subjects with Persistent AsthmaSubject with persistent asthmaMedDRA version: 19.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2014-000551-81-DEGlaxoSmithKline Research & Development Limited422